Alex Dav Inv. Share Discussion Threads

[harrysbank] 23/10/2013 07:56

Beaufort active with new to market co's?

Merlin Entertainments Share Offer
Merlin Entertainments has announced its Intention to Float on the London Stock Exchange and Beaufort have been appointed as an intermediary for private investors. Merlin Entertainments is Europe's leading visitor attraction operator and the second largest globally after Walt Disney, with brands including Alton Towers, Thorpe Park, Legoland Parks and SEA LIFE. The company has not announced when the Share Offer will open, but the Offer Period is likely to be short and investors may need to act swiftly. Click here for more information.

[harrysbank] 22/10/2013 18:00

Xmas bonus for Beaufort chaps - c'mon Rourke Xmas party date set - you don't want to turn up and have to sit in the corner do you?

[kennyruss] 22/10/2013 09:30

bottom fishing

[asmodeus] 22/10/2013 09:04

On the move again this morning. Why?

[asmodeus] 19/10/2013 20:53

You have an enviable love-life, Stenick.

[stenick] 19/10/2013 18:55

I think the manufacturing patent runs out in 2016, correct me if I'm wrong, then I can make it in my shed!

[harrysbank] 19/10/2013 10:28

hxxp://www.metagenics.com/corporate-overview

Regen (and therefore ADI) need these guys to sell like crazy in Jan 2014. Hopefully order taking now?!

[harrysbank] 19/10/2013 10:12

For any newer holders curious to understand more on ADI Regen Ltd relationship.
"Technically this loan [£270k] can be called upon after 14th February 2014, although at the election of either Alexander David Investments Plc ("ADI") or the Company it can be converted into Regen Therapeutics Limited Shares".

We anticipate Regen provides a c£20m IP and tax loss value (In Regen Finance statement 2011 "tax trading loses' were 'approx £14.2m' (page 15)

Brands from Regen Colostrinin include Zolpidem - this is one of many where no further work will be undertaken unless finances turn up for Regen

However, Dr Clauss continues to work with the product where NHS patients seek him out and results contine to provide encouragement

Example of his twitter updates (
Survivors of severe brain injuries may end up in a state of 'wakeful unresponsiveness' or in a minimally conscious state. Pharmacological treatments of patients with disorders of consciousness aim to improve arousal levels and recovery of consciousness. We here provide a systematic overview of the therapeutic effects of amantadine, apomorphine and zolpidem in patients recovering from coma.

[kennyruss] 17/10/2013 06:24

Agree HB.. PR is King in these markets

[harrysbank] 17/10/2013 05:58

hxxp://sterlingtechnology.com/human_about.htm
Update on talks would be nice
For completness: hxxp://www.regentherapeutics.com/

[genises] 16/10/2013 18:13

The combo looks very interesting for those with alzheimers but hey ho launch January 2014 loan repayment Feb2014 .
wonder if this is why no news has arrived from ADI.

[asmodeus] 16/10/2013 17:58

On the face of it this is the best news I have read for years, having opined repeatedly that the only way people could be persuaded to consume Colostrinin for any length of time would be for it to be included in a "health food" of some sort, and provided this is properly advertised and marketed. It could be the turning point - if the Company can survive up to, and past the launch in January.

[stenick] 16/10/2013 16:42

I wonder what they will call it!

[harrysbank] 11/10/2013 11:00

hxxp://www.regentherapeutics.com/report-and-financial-statements-year-ended-december-2012/

Revenues from sales of ColostrininTM for the year to 31 December 2012 were £65,000. For comparison purposes previously reported sales were £104,000 for 2011, £187,741 for 2010 and £56,055 for 2009.

On the positive side our USA licensee Metagenics has confirmed that they will be introducing a Colostrinin combination product via the 'professional' channel in January 2014. Preliminary discussions have taken place with several potential 'retail' distribution companies and discussions are ongoing with our contract manufacturing partner Sterling Technology Inc., with regard to the possibility of creating a 'joint-venture' partnership to exploit the USA retail market and specific markets in Asia where they already have business contacts and distributors for their own products.

[genises] 10/10/2013 16:48

wishful thinking

[stenick] 10/10/2013 15:58

Becos they have a turnover of over ' I think it is ' over £ 86,000 and the fact that they can claim the vat back on all expenses.

[doorway] 10/10/2013 00:58

so why have rgt got a vat number.....

[harrysbank] 09/10/2013 21:42

Chris Rourke (Beaufort Investments top man) is the acting non Exec Chair and calling the shots here.

Beaufort's corporate team (hxxp://www.beaufort-int.co.uk/index.php/our-services/corporate-finance) like to say they focus on;

"Introductions and IPOs

Our niche is bringing small and medium sized companies to market* (Main Market and AIM). We will impartially advise on the most suitable capital structure and route (Introduction, IPO or reverse acquisition) and guide management throughout the process"

*£25m - £250m market capitalised.

So with control over the ADI shell and their clients aware of what they do another "reverse acquisition" client won't be that far off.

[asmodeus] 09/10/2013 07:10

Good point, Gerri.

[greedfear] 04/10/2013 09:40

Why should one who isn't a shareholder refrain from posting?

I'm very interested in this share and curious where it will all end (you would know why if you knew some more about the company's history).

Anyway, BOL with your holding.